Duvelisib Induces Deep Responses in Peripheral T-Cell Lymphoma: Final Results of the Phase II PRIMO Trial of Duvelisib in Relapsed/Refractory Peripheral T-Cell Lymphoma. - Mehta-Shah N; Zinzani PL; Jacobsen ED; Zain J; Mead M; Casulo C; Gritti G; Pinter-Brown L; Izutsu K; Sidransky D; Bentur OS; Pro B; et al. (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2026)